Replies to post #94110 on Biotech Values

[turtlepower]

As the article below points out, one of the biggest problem for MON appears to be competition from chinese companies that are apparently flooding the market with cheaper seeds. While American farmers may be able to afford MON's seeds it appears that the farmers in developing countries can't or are able to achieve higher profits by using cheaper seeds.

http://finance.yahoo.com/news/Monsanto-sees-2ndqtr-profit-apf-2190622551.html?x=0&.v=14

[genisi]

Agree on the FUDBARS definition. If they have strong evidence against GM plants, they should present it to the public, not criticizing the already overburdened regulatory agencies. Of course there might be some adverse effects but they are negligent compared to the ample supply of food to the growing population. What can regulatory agencies do? Perform their own long term tests? Who is going to finance it? In pharma, the companies conduct follow up studies (phase IV). I have no objection that MON will be asked to do the same, which I think they are doing anyway.